Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |